---
$id: https://graph.org.ai/products/commodity/51142034
$type: Product
source: UNSPSC
code: "51142034"
title: "Xylazine"
class: "51142000"
classTitle: "Non narcotic analgesics and antipyretics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Xylazine

**UNSPSC Code**: 51142034
**Class**: [Non narcotic analgesics and antipyretics](Non narcotic analgesics and antipyretics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C12H16N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2KFG9TP5V8, chemically known as 5,6-dihydro-2-(2,6-xylidino)-4h-1,3-thiazine but generally known as xylazine, which bears US NIH Compound Identifier 5707. European Medicines Agency schedules Xylazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00120MIG. The term XYLAZINE is an International Non-Proprietary Name. XYLAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule xylazine under HS 29349990 and SITC 51579. As of Q4 2014, XYLAZINE remains the US FDA Preferred Term for this commodity. Xylazine bears US NLM identifiers UMLS ID C0043366 and NCI Concept Code C75049. SMILES: CC1=C(C(=CC=C1)C)NC2=NCCCS2.

